MOS
JAZZ icon

MGO One Seven’s Jazz Pharmaceuticals JAZZ Stock Holding History

MGO One Seven’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,235
Closed -$357K – 479
2020
Q2 		$357K Sell
3,235
-314
-9% -$34.7K 0.09% 294
2020
Q1 		$353K Sell
3,549
-209
-6% -$27K 0.12% 245
2019
Q4 		$560K Sell
3,758
-1,799
-32% -$245K 0.15% 199
2019
Q3 		$712K Buy
5,557
+856
+18% +$115K 0.2% 131
2019
Q2 		$670K Sell
4,701
-230
-5% -$30.9K 0.22% 135
2019
Q1 		$704K Buy
4,931
+2,450
+99% +$320K 0.23% 128
2018
Q4 		$307K Sell
2,481
-259
-9% -$38.4K 0.13% 171
2018
Q3 		$460K Buy
+2,740
New +$471K 0.22% 130
2018
Q1 		$175K Sell
1,160
-5
-0.4% -$733 0.08% 298
2017
Q4 		$157K Buy
+1,165
New +$162K 0.07% 321

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

MGO One Seven's JAZZ Position: Q3 2020 in Review

MGO One Seven sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2020, closing a stake of 3,235 shares — an estimated $357K sold.

MGO One Seven first reported a position in JAZZ in Q4 2017 and held it in 10 quarters. The position peaked at $712K in Q3 2019. 389 funds tracked by Wall St. Rank hold JAZZ as of Q3 2020.

  • MGO One Seven reported no remaining Jazz Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • MGO One Seven sold 3,235 Jazz Pharmaceuticals shares in Q3 2020, an estimated $357K.
  • MGO One Seven first reported a position in Jazz Pharmaceuticals in Q4 2017 and held it in 10 quarters.
  • MGO One Seven's Jazz Pharmaceuticals position peaked at $712K in Q3 2019.
  • 389 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2020.

Based on MGO One Seven's 13F filing for Q3 2020, filed 30 Oct 2020.